ArticleImmunotherapy advances2023

Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function.

Shuya Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.